Irish Patent No. 1121375, Re [2005] IEHC 411 (1 December 2005)

Irish Patent No. 1121375, Re [2005] IEHC 411 (1 December 2005)

The court has jurisdiction under s. 38(2) of the Patents Act, 1992 to allow the patentee to seek leave to amend the patent specification during revocation proceedings, even while maintaining the validity of the original claims, provided the application is brought timeously and all parties are informed of the patentee's position. The procedure avoids unnecessary duplication of trials and is consistent with principles of efficient case management and patent litigation.

Citation
[2005] IEHC 411
Parties
Petitioner: Norton Healthcare Limited; Respondent: Akzo Nobel N. V.
Jurisdiction
Ireland
Judgment Date
01 December 2005
Procedural Posture
Patent Revocation Petition / Pre Trial Interlocutory Judgment
Outcome
Application for leave to amend should be brought now; court directs that amendment application proceed in accordance with procedural rules.
Legal Topics
Patent Amendment, Patent Revocation, Jurisdiction, Case Management
Intellectual Property Patents Patent Amendment Patent Revocation Jurisdiction Case Management

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 10 Party arguments 2
Sign in to unlock

Parties

Norton Healthcare Limited

Petitioner

Akzo Nobel N. V.

Respondent

Procedural Posture

Patent Revocation Petition / Pre Trial Interlocutory Judgment

Legal Issues

  1. 1 Whether the court has jurisdiction under s. 38 of the Patents Act, 1992 to permit amendment of a patent specification during revocation proceedings while the patentee maintains the validity of the original claims
  2. 2 Whether the patentee may seek leave to amend only if the original claims are struck down
  3. 3 Whether the proposed amendment procedure avoids unnecessary duplication of trials and costs

Ratio Decidendi

The court has jurisdiction under s. 38(2) of the Patents Act, 1992 to allow the patentee to seek leave to amend the patent specification during revocation proceedings, even while maintaining the validity of the original claims, provided the application is brought timeously and all parties are informed of the patentee's position. The procedure avoids unnecessary duplication of trials and is consistent with principles of efficient case management and patent litigation.

Court Disposition

Application for leave to amend should be brought now; court directs that amendment application proceed in accordance with procedural rules.

Orders

  • Nobel must bring its application for leave to amend the patent specification now.
  • Procedures set forth by Part 63.10 of the CPR must be followed, including Nobel stating whether it will contend that the claims prior to amendment are valid.